Skip to main content
I

Improzo

Improzo provides AI-driven solutions specifically for the Life Sciences industry, focusing on Commercial, Medical, and R&D teams. The company integrates Customer Engagement Orchestration, CRM/Veeva excellence, and advanced analytics to enhance operational speed and decision-making. By leveraging Agentic AI and a proprietary data-tech ecosystem, Improzo delivers tailored technology transformations that improve field excellence and business outcomes.

Cambridge, United StatesFounded 2025273K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Life sciences companies face challenges in optimizing commercial strategies and accelerating research and development due to fragmented data, evolving regulatory landscapes, and the need for personalized engagement. Traditional approaches often fall short in delivering targeted insights and efficient operations.

Solution

Improzo provides an integrated data-tech-AI ecosystem designed to enhance commercial excellence and R&D velocity within the life sciences sector. The company leverages Generative AI and agentic AI to develop tailored strategies for pharmaceutical growth, focusing on areas like launch optimization, omnichannel engagement, and CRM. By integrating advanced analytics and digital transformation capabilities, Improzo aims to streamline operations and drive innovation across the value chain. Their solutions are built to address the complexities of the industry, offering a path to more efficient and effective business outcomes.

Target Audience

Improzo serves pharmaceutical and life sciences companies seeking to optimize their commercial operations, accelerate R&D, and leverage AI for strategic advantage.

Features

  • AI-powered solutions for commercial excellence, including launch, omnichannel, and CRM strategies.
  • Digital and technology transformation services to drive business growth.
  • Generative AI and agentic AI for enhanced efficiency and productivity.
  • AI-driven analytics and insights for patient and commercial success.
  • R&D acceleration through AI-driven analytics and digital transformation.
  • The iZO™ framework for secure, compliant, and scalable Conversational AI in life sciences.
  • AI risk detection, real-time guardrails, and continuous compliance monitoring for regulatory adherence.
  • Predictive analytics for precision targeting and sales forecasting.
  • Next Best Action (NBA) frameworks for optimizing HCP engagement across channels.
  • Data integration and unified data repositories for a single source of truth.
This profile is AI-generated and may contain inaccuracies.